Ads
related to: inflammatory demyelinating polyneuropathy- Disease Overview
Study the development of hATTR
amyloidosis, a progressive disease.
- Diagnosis
Consider this 3-step process to
help ensure an accurate diagnosis.
- Treatment Options
Read about treatment approaches for
your hATTR amyloidosis patients.
- Find a Physician
Find a physician who is experienced
in managing hATTR amyloidosis.
- Management Options
Read about management options for
your hATTR amyloidosis patients.
- Sign Up for Information
Receive updates about
hereditary ATTR amyloidosis.
- Disease Overview
Search results
Everything You Need to Know About POEMS Syndrome
Verywell Health via Yahoo News· 10 months agoA Rare Multisystem Disease Mladen Zivkovic / Getty Images Medically reviewed by Doru Paul, MD Polyneuropathy, organomegaly, endocrinopathy, monoclonal...
Guillain-Barré Syndrome (GBS): Everything You Need to Know
Verywell Health via Yahoo News· 6 months agoAlso Known as Acute Inflammatory Demyelinating Polyneuropathy (AIDP)Medically reviewed by David...
Olympic Swimmer Michael Klim Reveals CIDP Diagnosis: 'My Health Began to 'Deteriorate Drastically'
People via Yahoo News· 2 years agoHanna Lassen/Getty Australian Olympic swimmer Michael Klim is opening up about his recent health...
'A hospital within a hospital': St. Vincent Children’s Hospital expands services
Green Bay Press-Gazette via Yahoo News· 1 year agoGREEN BAY - It was a lot of firsts for 14-year-old Emma who came from Peshtigo to go to her first...
North Myrtle Beach man to be featured in national awareness campaign for rare disorder
WBTW Myrtle Beach via Yahoo News· 1 month agoHORRY COUNTY, S.C. (WBTW) — A North Myrtle Beach man with a rare autoimmune disorder will be...
5 Biotech Stocks That Could Be Big Winners in 2024 and Beyond
Motley Fool via Yahoo Finance· 4 months agoBiotech could be on the verge of a major comeback in 2024. The main reason for this expected...
The Multibillion-Dollar Opportunity That Sent Argenx Flying 28% Into A Breakout
Investor's Business Daily· 10 months agoAn Argenx drug beat Wall Street's expectations in a study of patients with a progressive nerve...
Why Shares of Argenx Jumped This Week
Motley Fool· 10 months agoShares of Argenx SE (NASDAQ: ARGX) were up more than 44% for the week as of 12:15 p.m. ET on Friday, according to data provided by S&P Global Market...
Immunovant (IMVT) Soars on Upbeat Initial IMVT-1402 Study Data
Zacks via Yahoo Finance· 8 months agoImmunovant, Inc. IMVT, a clinical-stage company, announced positive initial results from both...
Immunovant (IMVT) Q1 Loss Wider Y/Y, Pipeline in Focus
Zacks via Yahoo Finance· 10 months agoImmunovant, Inc. IMVT reported fiscal first-quarter 2023 net loss of 57 cents per share, wider than...
Ad
related to: inflammatory demyelinating polyneuropathy
